Abeona Therapeutics Inc (ABEO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.02
(+0.45%)
After-Hours: 20:00
Abeona Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2024 | 13.38 |
| March 27, 2024 | 13.54 |
| March 26, 2024 | 13.58 |
| March 25, 2024 | 13.65 |
| March 22, 2024 | 14.04 |
| March 21, 2024 | 13.89 |
| March 20, 2024 | 13.89 |
| March 19, 2024 | 13.97 |
| March 18, 2024 | 12.90 |
| March 15, 2024 | 15.92 |
| March 14, 2024 | 15.02 |
| March 13, 2024 | 15.18 |
| March 12, 2024 | 15.09 |
| March 11, 2024 | 14.41 |
| March 08, 2024 | 14.71 |
| March 07, 2024 | 15.22 |
| March 06, 2024 | 16.02 |
| March 05, 2024 | 15.61 |
| March 04, 2024 | 14.41 |
| March 01, 2024 | 14.41 |
| February 29, 2024 | 12.34 |
| February 28, 2024 | 12.34 |
| February 27, 2024 | 13.15 |
| February 26, 2024 | 13.49 |
| February 23, 2024 | 12.49 |
| Date | Value |
|---|---|
| February 22, 2024 | 11.99 |
| February 21, 2024 | 12.08 |
| February 20, 2024 | 12.06 |
| February 16, 2024 | 12.54 |
| February 15, 2024 | 11.61 |
| February 14, 2024 | 11.00 |
| February 13, 2024 | 11.29 |
| February 12, 2024 | 11.59 |
| February 09, 2024 | 11.09 |
| February 08, 2024 | 9.446 |
| February 07, 2024 | 8.766 |
| February 06, 2024 | 7.693 |
| February 05, 2024 | 7.675 |
| February 02, 2024 | 7.907 |
| February 01, 2024 | 7.693 |
| January 31, 2024 | 7.281 |
| January 30, 2024 | 8.015 |
| January 29, 2024 | 8.677 |
| January 26, 2024 | 8.390 |
| January 25, 2024 | 8.516 |
| January 24, 2024 | 8.516 |
| January 23, 2024 | 8.712 |
| January 22, 2024 | 9.088 |
| January 19, 2024 | 8.945 |
| January 18, 2024 | 8.891 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3745
Minimum
Dec 17 2021
16.02
Maximum
Mar 06 2024
2.752
Average
1.641
Median
Price to Book Value Benchmarks
| T2 Biosystems Inc | -- |
| INVO Bioscience Inc | -- |
| Perspective Therapeutics Inc | 4.333 |
| Electromed Inc | 3.333 |
| Xtant Medical Holdings Inc | 1.967 |
Price to Book Value Related Metrics
| Price | 4.40 |
| Earnings Yield | -72.73% |
| Market Cap | 179.73M |